The 13 analysts offering 12-month price forecasts for Acceleron Pharma Inc have a median target of 133.00, with a high estimate of 155.00 and a low estimate of 100.00. The median estimate represents a +25.27% increase from the last price of 106.17.
The current consensus among 13 polled investment analysts is to Buy stock in Acceleron Pharma Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.61
Reporting Date Nov 05
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.